Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Pineda Peña, Andrea Clemencia ^a,b   Schrooten, Yoeri ^a,c   Vinken, Lore ^a   Ferreira, Fossie ^a   Li, Guangdi ^a   Trovão, Nídia Sequeira ^a   Khouri, Ricardo ^a   Derdelinckx, Inge ^c,d   De Munter, Paul ^c,d   Kuc̈herer, Claudia ^e   Kostrikis, Leondios G ^f   Nielsen, Claus ^g   Littsola, Kirsi ^h   Wensing, Annemarie ⁱ   Stanojevic, Maja ^j   Paredes, Roger ^k   Balotta, Claudia ^l   Albert, Jan ^m,n   Boucher, Charles ^o   Gomez Lopez, Arley ^b   Van Wijngaerden, Eric ^c,d   Van Ranst, Marc ^a,c   Vercauteren, Jurgen ^a   Vandamme, Anne Mieke ^a,p   Van Laethem, Kristel ^a,c   more..

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e ROBERT KOCH INSTITUTE   (Germany)

^f UNIVERSITY OF CYPRUS   (Cyprus)

^g STATENS SERUM INSTITUT   (Denmark)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j UNIVERSITY OF BELGRADE   (Serbia)

^k IrsiCaixa Foundation   (Spain)

^l UNIVERSITY OF MILAN   (Italy)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^o ERASMUS MEDICAL CENTER   (Netherlands)

^p INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGED; ANTIVIRAL RESISTANCE; ARTICLE; BELGIUM; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE B; INFECTION; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PHYLOGENY; PREDICTION; PREVALENCE; SEQUENCE ANALYSIS; TRANSMITTED DRUG RESISTANCE; TREND STUDY; VIRUS LOAD; VIRUS TRANSMISSION; CLUSTER ANALYSIS; DRUG EFFECTS; GENETICS; GENOTYPE; HEALTH SURVEY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; PREGNANCY; RETROSPECTIVE STUDY; RISK FACTOR; TRANSMISSION; VIROLOGY; YOUNG ADULT;

ADULT; AGED; ANTI-HIV AGENTS; BELGIUM; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREGNANCY; PREVALENCE; PUBLIC HEALTH SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84903973524     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101738     Document Type: Article

References (47)

1. ISP-WIV (2012) Epidemiologie van AIDS en HIV infectie in België. Epidemiologie du SIDA et de l'infection à VIH en Belgique. In: Direction opérationnelle Santé publique et Surveillance, Service Maladies infectieuses au sein de la Population généra and Programme de surveillance VIH/SIDA/IST, editors.
2. European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2012) HIV/AIDS surveillance in Europe 2011. Stockholm: European Centre for Disease Prevention and Control.
3. Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, et al. (2007) High rates of forward transmission events after acute/early HIV-1 infection. The Journal of infectious diseases 195: 951-959. (Pubitemid 46452099)
4. Chalmet K, Staelens D, Blot S, Dinakis S, Pelgrom J, et al. (2010) Epidemiological study of phylogenetic transmission clusters in a local HIV-1 epidemic reveals distinct differences between subtype B and non-B infections. BMC infectious diseases 10: 262.
5. Karlsson A, Bjorkman P, Bratt G, Ekvall H, Gisslen M, et al. (2012) Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010. PLoS One 7: e33484.
6. Yerly S, von Wyl V, Ledergerber B, Boni J, Schupbach J, et al. (2007) Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS (London, England) 21: 2223-2229. (Pubitemid 350287221)
7. Callegaro A, Svicher V, Alteri C, Lo Presti A, Valenti D, et al. (2011) Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008. Infect Genet Evol 11: 624-632.
8. Wittkop L, Gunthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, et al. (2011) Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. The Lancet infectious diseases 11: 363-371.
9. Van Vaerenbergh K, Debaisieux L, De Cabooter N, Declercq C, Desmet K, et al. (2001) Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium. Antiviral therapy 6: 63-70. (Pubitemid 33704483)
10. Derdelinckx I, Van Laethem K, Maes B, Schrooten Y, De Wit S, et al. (2004) Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response. Journal of acquired immune deficiency syndromes (1999) 37: 1664-1666.
11. Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, et al. (2008) Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006. AIDS research and human retroviruses 24: 355-362. (Pubitemid 351457751)
12. Ruelle J, Ingels MG, Jnaoui K, Ausselet N, Vincent A, et al. (2013) Transmission Network of an HIV Type 1 Strain with K103N in Young Belgian Patients from Different Risk Groups. AIDS research and human retroviruses 29: 1306-1309.
13. Castro E, Khonkarly M, Ciuffreda D, Burgisser P, Cavassini M, et al. (2010) HIV-1 drug resistance transmission networks in southwest Switzerland. AIDS research and human retroviruses 26: 1233-1238.
14. Skoura L, Metallidis S, Buckton AJ, Mbisa JL, Pilalas D, et al. (2011) Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece. J Antimicrob Chemother 66: 2831-2837.
15. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, et al. (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (London, England) 17: 1871-1879. (Pubitemid 37070272)
16. UNAIDS-WHO (2011) When and how to use assays for recent infection to estimate HIV incidence at a population level. In: UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, editor editors. Geneva, Switzerland.
17. Maes B, Schrooten Y, Snoeck J, Derdelinckx I, Van Ranst M, et al. (2004) Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory. Journal of virological methods 119: 45-49. (Pubitemid 38510526)
18. Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, et al. (2009) Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 4: e4724.
19. Vercauteren J, Beheydt G, Prosperi M, Libin P, Imbrechts S, et al. (2013) Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response. PLoS One 8: e61436.
20. de Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, et al. (2005) An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics (Oxford, England) 21: 3797-3800. (Pubitemid 41535530)
21. Struck D, Perez-Bercoff D, Devaux C and Schmit JC (2010) COMET: A Novel approach to HIV-1 subtype prediction. 8th European HIV Drug Resistance Workshop. Sorrento, Italy.
22. Pineda-Pena AC, Faria NR, Imbrechts S, Libin P, Abecasis AB, et al. (2013) Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: Performance evaluation of the new REGA version 3 and seven other tools. Infect Genet Evol.
23. Stamatakis A (2006) RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics (Oxford, England) 22: 2688-2690.
24. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, et al. (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. Journal of virology 73: 152-160. (Pubitemid 28565356)
25. SPREAD (2008) Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS (London, England) 22: 625-635.
26. Vercauteren J, Wensing AM, van de Vijver DA, Albert J, Balotta C, et al. (2009) Transmission of drug-resistant HIV-1 is stabilizing in Europe. The Journal of infectious diseases 200: 1503-1508.
27. Rhee SY, Kantor R, Katzenstein DA, Camacho R, Morris L, et al. (2006) HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes. AIDS (London, England) 20: 643-651. (Pubitemid 43884290)
28. Edgar RC (2004) MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic acids research 32: 1792-1797.
29. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Molecular biology and evolution 28: 2731-2739.
30. Ragonnet-Cronin M, Hodcroft E, Hue S, Fearnhill E, Delpech V, et al. (2013) Automated analysis of phylogenetic clusters. BMC bioinformatics 14: 317.
31. Hue S, Clewley JP, Cane PA and Pillay D (2004) HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS (London, England) 18: 719-728. (Pubitemid 38541542)
32. Frentz D, Wensing AM, Albert J, Paraskevis D, Abecasis AB, et al. (2013) Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology 10: 36.
33. Kaye M, Chibo D and Birch C (2008) Phylogenetic investigation of transmission pathways of drug-resistant HIV-1 utilizing pol sequences derived from resistance genotyping. Journal of acquired immune deficiency syndromes (1999) 49: 9-16.
34. Yebra G, Holguin A, Pillay D and Hue S (2013) Phylogenetic and demographic characterization of HIV-1 transmission in Madrid, Spain. Infect Genet Evol 14: 232-239.
35. Drummond AJ and Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC evolutionary biology 7: 214.
36. Shapiro B, Rambaut A and Drummond AJ (2006) Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Molecular biology and evolution 23: 7-9. (Pubitemid 41785947)
37. Deforche K, Silander T, Camacho R, Grossman Z, Soares MA, et al. (2006) Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance. Bioinformatics (Oxford, England) 22: 2975-2979. (Pubitemid 44884070)
38. Frentz D, van de Vijver DA, Boucher CA and Albert J (2011) Estimates of HIV transmitted drug resistance can be inflated due to natural sequence polymorphisms. Journal of acquired immune deficiency syndromes (1999) 58: e135-137.
39. Descamps D, Assoumou L, Chaix ML, Chaillon A, Pakianather S, et al. (2013) National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011. J Antimicrob Chemother in press.
40. Frentz D, Van de Vijver DA, Abecasis AB, Albert J, Hamouda O, et al. (2012) The Epidemiology of HIV-1 Transmitted Drug Resistance: Increase in transmitted resistance to nonnucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. Department of Virology. Rotterdam, the Netherlands: Erasmus MC. pp. 77-94.
41. Readhead AC, Gordon DE, Wang Z, Anderson BJ, Brousseau KS, et al. (2012) Transmitted antiretroviral drug resistance in New York State, 2006-2008: results from a new surveillance system. PLoS One 7: e40533.
42. Abecasis AB, Wensing AM, Paraskevis D, Vercauteren J, Theys K, et al. (2013) HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology 10: 7.
43. Yebra G, de Mulder M, Perez-Elias MJ, Perez-Molina JA, Galan JC, et al. (2011) Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population. PLoS One 6: e26757.
44. Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, et al. (2009) Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology 6: 49.
45. Carr JK, Nadai Y, Eyzaguirre L, Saad MD, Khakimov MM, et al. (2005) Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan. Journal of acquired immune deficiency syndromes (1999) 39: 570-575.
46. Leigh Brown AJ, Lycett SJ, Weinert L, Hughes GJ, Fearnhill E, et al. (2011) Transmission network parameters estimated from HIV sequences for a nationwide epidemic. The Journal of infectious diseases 204: 1463-1469.
47. Centers for Disease Control and Prevention (2008) Revised Surveillance Case Definitions for HIV Infection Among Adults, Adolescents, and Children Aged < 18 Months and for HIV Infection and AIDS Among Children Aged 18 Months to <13 Years - United States, 2008. In: MMWR, editor editors. Atlanta. pp. 12.